AU

Biosceptre International Limited

Calculating rank
USPTO Granted Patents = 12

% Expired Patents = 25.0



Forward Citations = 213

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Julian Alexander Barden (11 out of 32 patents)

silverMedal Angus Gidley-Baird (11 out of 25 patents)

bronzeMedal Glenn Ronald Pilkington (2 out of 8 patents)

4.  Philip Jones (1 out of 13 patents)

5.  Neil Brewis (1 out of 5 patents)

6.  Steven Grant (1 out of 20 patents)

7.  Julia Alexander Barden (1 out of 1 patent)

8.  Augus Gidley-Baird (0 patent)

9.  Michael Slater (0 patent)


12 patents:

Company Overview
Biosceptre International Limited is an Australian biotechnology company focused on developing innovative therapeutic solutions for cancer treatment. The organization specializes in the research and commercialization of monoclonal antibodies and other biologics aimed at targeting cancer cells while minimizing damage to healthy tissues. With a commitment to advancing medical science, Biosceptre is dedicated to improving patient outcomes through its cutting-edge research and development efforts in the field of oncology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

12 Patents

#11 in

#320 in Australia

#48,334 in the World

AU
AU
Forward Citations = 213

7 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biosceptre International Limited. Retrieved from https://idiyas.com/company/biosceptre-international

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…